Please assess the completion status of the following clinical trial:

Trial Title: Letrozole vs Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovarian Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women age between 18-40 years.~* Normal husband semen analysis.~Exclusion Criteria:~* All infertile couples who had other causes of infertility than PCOS.~* Those who had recently taken these medications.~* Any contraindication to use of drugs e.g renal or hepatic dysfunction, hypersensitivity to this drug.~* BMI\>35 because obese women respond poorly to ovulation induction.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- letrozole (Type: EXPERIMENTAL): Patients were given letrozole 2.5 mg-7.5mg per day for 5 days started from 2nd day of menses.
- Clomiphene citrate (Type: ACTIVE_COMPARATOR): Patients were given clomiphene citrate 50-150mg per day for 5 days started from 2nd day of the menses.

Based on this trial design, predict the completion outcome and termination type (if applicable).